A B C D E F G H I J K L M N O P Q R S T U V W X Y Z # |
Ashkenazi Jewish Panel (4 Tests)
Test Code90994
Alias/See Also
LAB1795
ASHKENAZIC DISEASE SCREEN
ASHKENAZIC DISEASE SCREEN
CPT Codes
81220, 81255, 81200, 81260<br><strong>CPT coding may differ dependent on payer rules which may impact prior authorization testing.</strong><br><strong>Please direct any questions regarding CPT coding to the payer being billed.</strong>
Physician Attestation of Informed Consent
This germline genetic test requires physician attestation that patient consent has been received if ordering medical facility is located in AK, DE, FL, GA, IA, MA, MN, NV, NJ, NY, OR, SD or VT or test is performed in MA.
Includes
Cystic Fibrosis, Tay-Sachs DNA, Canavan Disease, Familial Dysautonomia
Preferred Specimen
5 mL whole blood collected in an EDTA (lavender-top) tube
Minimum Volume
3 mL
Other Acceptable Specimens
Whole blood collected in: EDTA (royal-blue) top tube, ACD solution A or B (yellow-top) tube, sodium heparin (green-top) tube or lithium heparin (green-top) tube • Amniotic fluid • Cultured amniocytes • Extracted DNA • Bone marrow • Chorionic Villus sample
Instructions
Whole blood: Specimen stability is crucial. Store and ship at room temperature immediately. Do not freeze.
Transport Container
EDTA (lavender-top) tube
Transport Temperature
Room temperature
Specimen Stability
Room temperature: 8 days
Refrigerated: 8 days
Frozen: Unacceptable
Refrigerated: 8 days
Frozen: Unacceptable
Reject Criteria (Eg, hemolysis? Lipemia? Thaw/Other?)
Received frozen
Methodology
Multiplex PCR • Massively Parallel Sequencing • Polymerase Chain Reaction (PCR) • Next Generation Sequencing
FDA Status
This test was developed and its analytical performance characteristics have been determined by Quest Diagnostics. It has not been cleared or approved by FDA. This assay has been validated pursuant to the CLIA regulations and is used for clinical purposes.
Setup Schedule
Mon, sat
Reference Range
See Laboratory Report
Clinical Significance
This panel consists of the diseases frequent in the Ashkenazi Jewish population that have been recommended for population based carrier screening by the Americal College of Obstetricians and Gynecologists (ACOG) and the American College of Medical Genetics. This panel screens for Cystic Fibrosis, Tay-Sachs (DNA), Canavan Disease, and Familial Dysautonomia.
Performing Laboratory
Quest Diagnostics Nichols Institute-San Juan Capistrano, CA |
33608 Ortega Highway |
San Juan Capistrano, CA 92675-2042 |